ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Sponsor message

Trusted custom mooring solution design, deployment and monitoring

Congress Asked Not To Interfere With FDA

by 5m Editor
3 August 2011, at 1:00am

US - A letter has been sent by 38 industry groups asking members of Congress not to interfere in the science-based regulatory process of the Food and Drug Administration (FDA).

The letter was sent in response to the letter sent two weeks ago by several Senators and Representatives asking the FDA to halt the review process of AquaBounty’s AquAdvantage salmon.

The letter highlights the groups' concerns over the House of Representatives action of prohibiting the FDA from spending funds on the finalisation of an application for genetically modified salmon.

However, the groups stress that they are neither supporting or opposing the specific application.

Simply, they believe that the FDA should be left to make its own decisions and that any interference with these decisions reduces the credibility of the FDA.

"It is the principle behind the amendment and its wider ramifications. It sends the message to the rest of the world that the science-based regulatory oversight as embodied in the FDA review process is subject to political intervention."

"Furthermore, it signals to the world that the US may cede its leadership position in the agricultural use of biotechnology."

Further Reading

- Go to our previous news item on this story by clicking here.

5m Editor

Sponsored content